There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To develop salinomycin-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated
with both CD133 aptamers A15 and EGFR aptamers CL4 (CESN), to target hepatocellular
carcinoma (HCC) cells simultaneously expressing EGFR and CD133.